Physician profile
John Brian Jacquemin
NPI 1316993686
$3,850.99
in general payments reported to CMS, 2019-2025
12 companies · $436 in 2025
The $436 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $415 · 2021: $429 · 2022: $305 · 2023: $1,970 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,215 · Food and Beverage: $1,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,214.71 |
| Food and Beverage | $1,191.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,735.51 | 2021-2025 | Pivox Oblique Lateral Spinal System, Kyphon Express II Kyphopak Tray, Clydesdale Ptc Spinal System |
| Nuvasive, INC. | $478.86 | 2023 | Xlif |
| Medtronic USA, INC. | $302.63 | 2019-2020 | |
| Boston Scientific Corporation | $289.80 | 2019-2021 | |
| Abbott Laboratories | $245.50 | 2023-2025 | Eterna, Proclaim |
| Depuy Synthes Sales INC. | $234.61 | 2020-2021 | |
| Relievant Medsystems, INC. | $158.45 | 2023 | Intracept |
| Globus Medical, INC. | $136.10 | 2021-2025 | Reline |
| Kuros Biosciences USA, INC | $109.81 | 2023 | |
| Pacira Therapeutics, INC. | $70.27 | 2020 | |
| Cerapedics INC. | $49.90 | 2019 | |
| Ethicon US, LLC | $39.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jacquemin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.